Press "Enter" to skip to content

Tag: Europe

Wildfire smoke far more dangerous to health than thought, say scientists

Choking smoke spewed by wildfires is far more dangerous than previously thought, a new study has found, with death tolls from short-term exposure to fine particulates underestimated by 93%.

Researchers found that 535 people in Europe died on average each year between 2004 and 2022 as a result of breathing in the tiny toxic particles known as PM2.5 that are released when wildfires rage.

Under standard methods, which assume PM2.5 from wildfires is as deadly as from other sources, such as traffic, they would have expected just 38 deaths a year.

Comments closed

Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.

Eli Lilly said Thursday that it would increase the prices of medicines in Europe and other developed markets “in order to make them lower” in the U.S., an apparent response to the Trump administration’s calls to do so. It singled out the list price of its popular weight-loss drug in the U.K. as part of that effort.

The announcement is among the first moves by a major drugmaker to raise prices abroad in order to lower them in the U.S., in line with President Trump’s agenda. But it’s not clear if these actions would actually increase the amount of revenue that Lilly earns abroad, since governments and private providers that cover drugs often negotiate discounts off the list prices. Lilly did not immediately announce any new price reductions in the U.S.

Comments closed

COVID hospitalization linked to cognitive impairment 2 years later

Almost 20% of people who were hospitalized for COVID-19 infections early in the pandemic still had signs of impairment with brain function 2 years after infection, finds a new study in Scientific Reports.

The study population came from Portugal, in a region hit hard by the first wave of the COVID-19 pandemic. Based on hospital admission episodes and SARS-CoV-2 infection status from March 2020 to February 2021, the authors identified four groups: group 1 (101) hospitalized for COVID-19 infections, group 2 (87) hospitalized but uninfected with COVID-19, group 3 (252) infected but not requiring hospitalization, and group 4 (258) uninfected and not hospitalized for any reason.

Cognitive assessments were conducted in two parts 2 years after infection, a general screening using the Montreal Cognitive Assessment and a subsequent neuropsychological assessment conducted by one of four psychologists if the score of the general screening was low. Overall, verbal memory, visual memory, executive functions, language, and information processing speed and attention were evaluated.

Comments closed

Childhood vaccines were a global success story. Misinformation and other obstacles are slowing that progress, a study shows

Routine vaccines have prevented the deaths of about 154 million children around the world over the past 50 years, a new study shows, but efforts have been slowing recently, allowing for the growth of some vaccine-preventable diseases. This backslide could lead to many more unnecessary illnesses and deaths without an increased effort to vaccinate children and counter misinformation.

The report, published Tuesday in the medical journal The Lancet, says that over the past five decades, the World Health Organization’s Expanded Programme on Immunization has vaccinated more than 4 billion children. This doubling of global coverage of vaccines has prevented countless cases of tuberculosis, measles, polio, diphtheria, tetanus and pertussis.

Comments closed

COVID-19 Disease Burden Remains Greater Than Influenza, Study Shows

Researchers in Denmark conducted a large-scale evaluation of the disease burdens associated with COVID-19 and influenza. Their conclusion? COVID-19 has a greater impact than influenza, resulting in more hospitalizations and deaths. These findings, they note, emphasize the continued need for a strong public health response.

COVID-19 Exhibits Greater Disease Burden Than Influenza

To compare the disease burden of COVID-19 and influenza, the researchers evaluated data available from Danish health registries from May 16, 2022 to June 7, 2024. The results were published in The Lancet Infectious Diseases. A commentary about the findings was published in the same issue of the journal.

During this period, the risk of hospitalization due to COVID-19 was approximately two times higher than the risk of hospitalization due to influenza. The risk of death was approximately three times higher. The researchers note that these increased risks were greater during the first year of the study period but still were evident during the second year. The risk of mortality, for example, was five times greater for COVID-19 during the first year of the study. That increased risk dropped during the second year, but COVID-19 still had a two and a half times greater risk of mortality than influenza.

Comments closed

Scientists have lost their jobs or grants in US cuts. Foreign universities want to hire them

As the Trump administration cut billions of dollars in federal funding to scientific research, thousands of scientists in the U.S. lost their jobs or grants…

Comments closed

ME/CFS cases in England higher than first projected

Almost two-thirds more people are living with ME/CFS in England than previously thought, a study says.

The new estimate suggests that approximately 404,000 people are affected by ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome), a 62 per cent rise from the previously accepted figure of 250,000.

Comments closed

Young people with long Covid ‘battle’ for NHS care

Young people living with debilitating symptoms caused by long Covid have described feeling abandoned and having to “battle” to access NHS support.

Kaylee, 17, a once promising gymnast who hoped to represent her country, developed the virus on her 12th birthday and still experiences symptoms including dizziness and shortness of breath, causing her to miss school and give up on the sport she loves.

Two million people in the UK have long Covid, according to the Office for National Statistics.

Comments closed

‘We’re losing decades of our life to this illness’: long Covid patients on the fear of being forgotten

Five years on from March 2020, millions of people still face debilitating symptoms, with huge repercussions on public health and productivity. But politicians are starting to pretend the pandemic never happened

On 20 March 2020, Rowan Brown started to feel a tickle at the back of her throat. Over the next few days, new symptoms began to emerge: difficulty breathing, some tiredness. By the following week, the UK had been put under lockdown in a last-minute attempt to contain the spread of SARS-CoV-2, or Covid-19. No one else she knew had yet been infected, so she posted updates on Facebook to keep people informed: “Oh, guys, it feels like a mild flu. Tonsillitis was definitely worse.”

Brown didn’t know then she was at the beginning of a condition that did not yet have a name, but which has since become known as long Covid. After two weeks, she had a Zoom with a friend, and at the end of the conversation it was as if all life force had drained out of her body. Her doctor advised her to stay in bed for two weeks. Those two weeks turned into three and a half months of extended Covid symptoms: nausea, fevers, night sweats, intense muscle and joint pain, allodynia (a heightened sensitivity to pain), hallucinations, visual disturbances. By the end of the three months, she had noted 32 different symptoms. “I didn’t recognise the way my body felt at all: my skin, my hair,” she remembers now. “It was like being taken over by a weird alien virus, which I guess is what happened.”

Comments closed

UK orders H5 avian flu vaccine for pandemic preparedness

The UK Health Security Agency (HSA) today announced a contract with CSL Seqirus to buy more than 5 million doses of human H5 avian flu vaccine to prepare for a potential influenza pandemic.

In a statement, the HSA said the vaccine will be based on a current H5 strain and is part of a longer-term plans to ensure access to vaccines for a wider range of pathogens that have pandemic potential.

Comments closed

Long Covid could cost the economy billions every year

Working days lost to long Covid could be costing the economy billions of pounds every year as patients struggle to cope with symptoms and return to work, finds a new study led by UCL researchers.

Comments closed

Tour de France Reinstates COVID-19 Measures as More Cases Emerge in the Peloton

The Tour de France has reinstated COVID-19 protective measures, requiring race organizers, media, and guests to wear masks when in contact with riders and team staff. This protocol was announced by race organizer ASO on Sunday morning after several recent COVID-19 cases among the peloton.

“In order to limit health risks, it is now compulsory to wear a mask in the various areas where you will be in contact with the riders and members of the cycling teams,” read the statement from the ASO.

Riders who have abandoned the race due to the virus include Tom Pidcock (INEOS Grenadiers), Juan Ayuso (UAE Team Emirates), and Michael Mørkøv (Astana-Qazaqstan). Geraint Thomas (INEOS Grenadiers) remains in the Tour despite testing positive, as the rules currently allow.

Comments closed

Finland to start bird flu vaccinations for humans, in world first

Finland plans to offer preemptive bird flu vaccination as soon as next week to some workers with exposure to animals, health authorities said on Tuesday, making it the first country in the world to do so.

The Nordic country has bought vaccines for 10,000 people, each consisting of two injections, as part of a joint EU procurement of up to 40 million doses for 15 nations from manufacturer CSL Seqirus (CSL.AX).

The European Commission said Finland would be the first country to roll out the vaccine.

Comments closed

UK Covid hospitalisations increase following emergence of new variant

Experts have warned that Covid “hasn’t gone away” after an uptick in infections and hospitalisations that is thought to have been caused by new variants of the virus.

A group of Covid mutations has recently emerged and is collectively referred to as FLiRT.

According to the UK Health Security Agency (UKHSA), Covid hospital admissions increased by 24 per cent in the week to Sunday, with a rate of 3.31 per 100,000 people compared with 2.67 per 100,000 in the previous week.

Comments closed

Scientists discover higher levels of CO2 increase survival of viruses in the air and transmission risk

A new study has revealed for the first time the vital role carbon dioxide (CO2) plays in determining the lifespan of airborne viruses – namely SARS-CoV-2, the virus that causes COVID-19.

It clearly showed keeping CO2 levels in check helps to reduce virus survival, and therefore the risk of infection.

The research, led by the University of Bristol and published today in Nature Communications, shows how CO2 is a major factor in prolonging the life of SARS-CoV-2 variants present in tiny droplets circulating in the atmosphere.

Comments closed

About 2m people have long Covid in England and Scotland, figures show

About 2 million people in England and Scotland say they are experiencing long Covid, figures reveal, with many reporting their symptoms have lasted two years or longer.

The findings were released by the Office for National Statistics (ONS) and cover the period from November 2023 to March 2024, revealing of those who reported having long Covid, about 1.5 million people – about three-quarters– felt their day-to-day activities were affected, while 381,000 people – about a fifth – said their ability to undertake such activities had been “limited a lot”.

Comments closed

COVID Patient’s Infection Lasts Record 613 Days—and Accumulated Over 50 Mutations

A Covid-19 patient with a weakened immune system incubated a highly mutated novel strain over 613 days before succumbing to an underlying illness, researchers in the Netherlands found.

The patient, a 72-year-old man with a blood disorder, failed to mount a strong immune response to multiple Covid shots before catching the omicron variant in February 2022. Detailed analysis of specimens collected from more than two dozen nose and throat swabs found the coronavirus developed resistance to sotrovimab, a Covid antibody treatment, within a few weeks, scientists at the University of Amsterdam’s Centre for Experimental and Molecular Medicine said. It later acquired over 50 mutations, including some that suggested an enhanced ability to evade immune defenses, they said.

Comments closed

Discovery of how COVID-19 virus replicates opens door to new antiviral therapies

A new study, looking at the replication stage of the SARS-CoV-2 virus that causes COVID-19, discovered important mechanisms in its replication that could be the foundation for new antiviral therapies.

The study, which set out to investigate how the SARS-CoV-2 virus replicates once it enters the cells, has made surprising discoveries that could be the foundation for future antiviral therapies. It also has important theoretical implications as the replication of the SARS-CoV-2 virus has, so far, received less attention from researchers.

Comments closed